Back to results
TerminatedPhase 4

LANTUSTITR: Insulin Glargine in Type 2 Diabetes Mellitus

NCT00349986

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Sanofi-Aventis

Budapest, Hungary

View on ClinicalTrials.gov
LANTUSTITR: Insulin Glargine in Type 2 Diabetes Mellitus — TrialFind